A new study led by researchers at Washington University School of Medicine in St. Louis has found that an investigational ...

As Ebola rages, Moderna and others are racing to develop an mRNA vaccine for the rare Bundibugyo virus driving the current ...

Moderna’s investigational mRNA flu vaccine generated broader, longer-lasting immune responses than a standard flu shot.

A more effective vaccine technology may be on the horizon. In a new study in mice, researchers from the University of Copenhagen demonstrate that a simple addition to mRNA vaccines can significantly ...

A new study led by researchers at Washington University School of Medicine in St. Louis has found that an investigational mRNA influenza vaccine helps ...

Moderna (NASDAQ:MRNA) announced on Monday a new collaboration with an international health organization aimed at accelerating ...

In a study published in The Lancet, researchers at The University of Texas Medical Branch (UTMB) report the development of ...

Moderna gains up to $50M from CEPI to advance a Bundibugyo ebolavirus vaccine as the partnership expands amid an ongoing ...

A single-dose mRNA vaccine provided complete protection against the deadly Andes hantavirus infection in the Syrian hamster model.

As scientists race to develop a new Ebola vaccine to combat the Bundibugyo species, a few leading candidates have emerged.